SAN DIEGO, May 22, 2017 -- The MEPS Real-Time, Inc. (MEPS®) Board of Directors announced that Shariq Hussain is stepping down as Chief Executive Officer and the Board has named Gordon Krass as the company’s new CEO effective today. Following the transition, Hussain will assume the Chief Technology Officer role and will serve on the company’s board in an Emeritus advisory position.
Recently, health issues prompted Hussain to approach the Board to recommend a succession plan. "Our company’s evolution requires a level of focus I am unable to provide right now as I need to be personally focused on my own healing and rehabilitation,” Hussain said. “I’m confident we are in good hands with Gordon to support the success we’ve achieved to date and to lead the strategic growth plan we’ve outlined.”
As CTO, Hussain will continue to guide product innovation for the company’s Intelliguard® RFID Solutions for both hospital and health system pharmacy operations, plus a growing solution portfolio for adjacent healthcare markets.
Krass brings more than 25 years of executive experience with start-up and Fortune 500 companies in the medical device and telecommunications industries. Most recently, he served as President and Chief Client Officer of NobelBiz, a telecommunications and software company. Prior to NobelBiz, Krass spent 16-plus years with IVAC Corporation (ALARIS Medical Systems Inc./CareFusion Corp.), where he served in several leadership positions, including as Vice President of Marketing and Sales.
Previously, Krass was Vice President of Sales and a member of the leadership team at LMA North America, Inc., a medical device company that introduced new technology into the anesthesia market. Under his leadership, LMA achieved more than 40 percent market share within five years. He was also an executive at Kinetic Surgical, a start-up medical device company that developed new surgical technology, and part of the executive team that negotiated the sale of the company to Cardinal Health, Inc.
"I’m excited to be joining MEPS," Krass said. “The company has a strong technology foundation built on solid intellectual property. With our Intelliguard RFID Solutions already in use by more than 400 pharmaceutical, healthcare and life sciences partners, we are well positioned to lead ongoing innovation and value for our customers and growth for our employees and shareholders.”
About MEPS Real-Time, Inc. and Intelliguard® RFID Solutions for Critical Inventory™
MEPS Real-Time, Inc. (mepsrealtime.com) is a leading innovator of Radio Frequency Identification (RFID) solutions for pharmacy inventory management applications. Intelliguard® RFID Solutions provide unparalleled real-time visibility of critical inventory in healthcare. We develop patented technology and processes with an unwavering commitment to accuracy to eliminate human error, improve cost control, reduce risk, and increase efficiency. Intelliguard® RFID Solutions include Kit and Tray Management, Linked Visibility Inventory System™ for the OR, Inventory Management, and Vendor Managed Inventory Systems. MEPS Real-Time® is a charter member of RAIN RFID global alliance.
Dave Clifton 801-656-5541 [email protected]


Alibaba-Backed Moonshot AI Unveils Kimi K2.5 to Challenge China’s AI Rivals
China Approves First Import Batch of Nvidia H200 AI Chips Amid Strategic Shift
LVMH Investors Watch Earnings Closely as Luxury Recovery Faces New Challenges
ASML’s EUV Lithography Machines Power Europe’s Most Valuable Tech Company
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
Google Disrupts Major Residential Proxy Network IPIDEA
Puma’s Historic Rivalry With Adidas Enters a New Era as Anta Deal Signals Turnaround Push
SoftBank Shares Surge as It Eyes Up to $30 Billion New Investment in OpenAI
Tesla Q4 Earnings Beat Expectations as Company Accelerates Shift Toward AI and Robotics
Tesla Loses Ground in Europe as BYD Accelerates EV Market Share in 2025
Volkswagen CEO Oliver Blume Faces Crucial Year as Investors Demand Turnaround Results
NVIDIA, Microsoft, and Amazon Eye Massive OpenAI Investment Amid $100B Funding Push
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors
Elon Musk Reportedly Eyes June 2026 SpaceX IPO Timed With Planetary Alignment and Birthday
BYD and Exxon Mobil Strengthen Hybrid Technology Partnership 



